Zdrowie i gospodarka · 17/03/2003

FDA Corrects Labeling Requirements for Systemic Antibacterial Drug Products

The Food and Drug Administration (FDA) is correcting a final rule that was published with an error, requiring systemic antibacterial drug products intended for human use to include statements about reducing the development of drug-resistant bacterial strains.